18 September, 2023
No comment
The companies are a unique blend of talented researchers and aspiring companies all striving for innovation in their designated discipline.
While the Park is made up of many individual companies, it functions as a community with encouraged cooperative communication between the tenants.
Atterx Biotherapeutics, Inc is a R&D/Clinical stage biotechnology company that is developing novel therapies for the prevention and treatment of bacterial infections. Our lead product prevents urinary tract infections, including those caused by using a catheter for bladder management. A second product is a topical antibiotic that treats Gram-negative bacterial infections of wounds.